These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9263127

  • 21. Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor.
    Atmani F, Mizon J, Khan SR.
    Eur J Biochem; 1996 Mar 15; 236(3):984-90. PubMed ID: 8665922
    [Abstract] [Full Text] [Related]

  • 22. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
    Golding B, Inman J, Highet P, Blackburn R, Manischewitz J, Blyveis N, Angus RD, Golding H.
    J Virol; 1995 Jun 15; 69(6):3299-307. PubMed ID: 7745677
    [Abstract] [Full Text] [Related]

  • 23. The crystal structure of bikunin from the inter-alpha-inhibitor complex: a serine protease inhibitor with two Kunitz domains.
    Xu Y, Carr PD, Guss JM, Ollis DL.
    J Mol Biol; 1998 Mar 13; 276(5):955-66. PubMed ID: 9566199
    [Abstract] [Full Text] [Related]

  • 24. Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae.
    Pohlig G, Fendrich G, Knecht R, Eder B, Piechottka G, Sommerhoff CP, Heim J.
    Eur J Biochem; 1996 Oct 15; 241(2):619-26. PubMed ID: 8917464
    [Abstract] [Full Text] [Related]

  • 25. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system.
    Di Marco S, Priestle JP.
    Structure; 1997 Nov 15; 5(11):1465-74. PubMed ID: 9384562
    [Abstract] [Full Text] [Related]

  • 26. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition.
    Stubbs MT, Morenweiser R, Stürzebecher J, Bauer M, Bode W, Huber R, Piechottka GP, Matschiner G, Sommerhoff CP, Fritz H, Auerswald EA.
    J Biol Chem; 1997 Aug 08; 272(32):19931-7. PubMed ID: 9242660
    [Abstract] [Full Text] [Related]

  • 27. Biological activities of granzyme K are conserved in the mouse and account for residual Z-Lys-SBzl activity in granzyme A-deficient mice.
    Wilharm E, Tschopp J, Jenne DE.
    FEBS Lett; 1999 Oct 01; 459(1):139-42. PubMed ID: 10508933
    [Abstract] [Full Text] [Related]

  • 28. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
    Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JA, McClure MO, Thomson S, Marsh M.
    AIDS Res Hum Retroviruses; 1991 Jan 01; 7(1):3-16. PubMed ID: 2015114
    [Abstract] [Full Text] [Related]

  • 29. Quantitative analysis of bikunin-laden mast cells in follicular eruptions and chronic skin lesions of atopic dermatitis.
    Isogai R, Matsukura A, Aragane Y, Maeda A, Matsukura M, Yudate T, Sugihara K, Takahashi M, Aisu K, Tezuka T.
    Arch Dermatol Res; 2002 Dec 01; 294(9):387-92. PubMed ID: 12522575
    [Abstract] [Full Text] [Related]

  • 30. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H, Sugino D, She MY, Ohi H, Hirashima Y, Shinohara H, Fujie M, Shibata K, Terao T.
    Eur J Biochem; 1998 May 01; 253(3):817-26. PubMed ID: 9654084
    [Abstract] [Full Text] [Related]

  • 31. Bikunin target genes in ovarian cancer cells identified by microarray analysis.
    Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, Suzuki M, Itoh H, Terao T.
    J Biol Chem; 2003 Apr 25; 278(17):14640-6. PubMed ID: 12571229
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D, McBride JD, Leatherbarrow RJ.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6045-52. PubMed ID: 15519150
    [Abstract] [Full Text] [Related]

  • 33. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
    Kido H, Beppu Y, Imamura Y, Chen Y, Murakami M, Oba K, Towatari T.
    Biopolymers; 1999 Dec 01; 51(1):79-86. PubMed ID: 10380355
    [Abstract] [Full Text] [Related]

  • 34. Recombinant aprotinin homologue with new inhibitory specificity for cathepsin G.
    Brinkmann T, Schnierer S, Tschesche H.
    Eur J Biochem; 1991 Nov 15; 202(1):95-9. PubMed ID: 1718753
    [Abstract] [Full Text] [Related]

  • 35. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
    Savarino A, Bensi T, Chiocchetti A, Bottarel F, Mesturini R, Ferrero E, Calosso L, Deaglio S, Ortolan E, Buttò S, Cafaro A, Katada T, Ensoli B, Malavasi F, Dianzani U.
    FASEB J; 2003 Mar 15; 17(3):461-3. PubMed ID: 12551845
    [Abstract] [Full Text] [Related]

  • 36. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry.
    Fantini J, Hammache D, Delézay O, Yahi N, André-Barrès C, Rico-Lattes I, Lattes A.
    J Biol Chem; 1997 Mar 14; 272(11):7245-52. PubMed ID: 9054420
    [Abstract] [Full Text] [Related]

  • 37. Formation of active monomers from tetrameric human beta-tryptase.
    Fajardo I, Pejler G.
    Biochem J; 2003 Feb 01; 369(Pt 3):603-10. PubMed ID: 12387726
    [Abstract] [Full Text] [Related]

  • 38. A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells.
    Murakami T, Hattori T, Takatsuki K.
    Biochim Biophys Acta; 1991 Sep 20; 1079(3):279-84. PubMed ID: 1911851
    [Abstract] [Full Text] [Related]

  • 39. Expression of a functional proteinase inhibitor capable of accepting xylose: bikunin.
    Falkenberg C, Wester L, Belting M, Eklund E, Akerström B.
    Arch Biochem Biophys; 2001 Mar 01; 387(1):99-106. PubMed ID: 11368189
    [Abstract] [Full Text] [Related]

  • 40. Bikunin--not just a plasma proteinase inhibitor.
    Fries E, Blom AM.
    Int J Biochem Cell Biol; 2000 Feb 01; 32(2):125-37. PubMed ID: 10687949
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.